Chargement en cours...
The current state of GPCR‐based drug discovery to treat metabolic disease
One approach of modern drug discovery is to identify agents that enhance or diminish signal transduction cascades in various cell types and tissues by modulating the activity of GPCRs. This strategy has resulted in the development of new medicines to treat many conditions, including cardiovascular d...
Enregistré dans:
| Publié dans: | Br J Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177613/ https://ncbi.nlm.nih.gov/pubmed/29394497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14157 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|